Prognostic impact of sarcopenia on 5-year overall and progression-free survival in lung cancer patients: a prospective cohort study

Key Points

• Sarcopenia significantly reduces overall survival and progression-free survival in lung cancer patients.
• Independent predictor of poor survival found in specific high-risk subgroups with sarcopenia.
• Assessment of muscle function is crucial when evaluating prognosis in lung cancer patients.
• Early identification of sarcopenia may lead to better management strategies for affected individuals.

Abstract